ArticleInternational journal of oncology2018

Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.

Anja C Mortensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.